Molecular Diagnosis & Therapy

Papers
(The H4-Index of Molecular Diagnosis & Therapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects162
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker107
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review86
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors74
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”71
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate56
A Window of Opportunity for Newborn Screening53
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors48
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target45
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models41
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma38
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?38
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights36
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors31
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk31
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach29
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics28
Personalizing Oncolytic Immunovirotherapy Approaches26
Afamitresgene Autoleucel: First Approval25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease25
Correction to: Revakinagene Taroretcel: First Approval24
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders24
Advances and Challenges in the Diagnosis of Leishmaniasis23
0.082995176315308